Exchange: NASDAQ·Updated 05:45 PM EDT
BCDA logo

BCDA BioCardia Inc.

$0.861
$0.065
(7.02%)
Today
Closed $0.861
$0.00
(0.00%)
After Hours
Reported EarningsAug 12
Mkt Cap$13.03M
Vol79,317.00

About BCDA

BioCardia, Inc. is a clinical-stage biotherapeutic company, which engages in the business of developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its pipeline includes CardiAMP, CardiALLO, PulmALLO, Helix Biotherapeutic Delivery System, and Morph DNA and AVANCE Steerable Introducers. The company was founded on January 12, 1994 and is headquartered in Sunnyvale, CA.
33

Bearish Sentiment

How do you feel about BCDA?

Jusme
$BCDA How Novel Is the Helix? A True Category-Creator BioCardia's CEO stated the goal plainly: this pre-submission "should lead to our Helix catheter being the first approved transendocardial delivery catheter system in the United States." That's the critical framing — not "better than the competition" but the only one of its kind with FDA clearance.
2
3
Stock_Catcher
$BCDA BioCardia Announces FDA Acceptance of De Novo Pre-Submission Package for Helix™ Catheter Marketing Clearance FDA Substantive Review and Meeting Expected this Quarter
4
Jusme
$BCDA Could be an interesting week. BioCardia Files Revised De Novo Pre-Submission for FDA Approval of Helix™ Catheter on Oct 1. “The FDA targets providing an initial acceptance/refusal review within 15 calendar days and aims to issue written feedback or hold a meeting within 70 calendar days.”
3
Jusme
$BCDA Get ready for BOOM! It likely won’t be tied to a catalyst event. With no explanation the stock will go through the ceiling… peops on the sifelines and bleachers wondering what happened. It might be based on a key catalyst, or it could be based on majority shareholders forcing price higher because… well, because they can….. and then we have a new trading range - maybe $6 or higher.
3
Wizee13
$BCDA couldn't help myself, had to buy more... I fear this is your last chance to get it near 1$..👈👈
3
focafoca99
$BCDA indicated FDA acceptance of its Helix Catheter De Novo pre-submission package, with a review meeting expected this quarter.
2
Merlintrader
Latest company news, October 19, 2026: The FDA accepted BioCardia's updated De Novo pre-submission package for the Helix catheter; written FDA feedback and a meeting are expected this quarter. A pre-submission is a request for feedback, not a marketing application or clearance. BioCardia ($BCDA) Stock Hub: Can Helix and Japan Advance Within the Funding Window? Not investment advice. More details in our stock hub.
1
Whateverbro
$BCDA I really hope ones they submit the PMDA. that will really ouch the price up what’s your thoughts
1
Wizee13
$BCDA Haha, off day with this stock. Nobody wants to make their move. Peter show them how it's done😋
Wizee13
$BCDA looks like peter is out of money with those 500 share chunks, but he still keeps buying🤝 maybe I should too

Advertisement|Remove ads.